Takeda Pharmaceutical Company Limited Stock NYSE
Stocks
TAK
US8740602052
Pharmaceuticals
OTC Markets Traded|
Market Closed -
NYSE
16:00:03 2026-09-14 EDT
|
5-day change | 1st Jan Change | ||
| 18.60 USD | +1.86% |
|
+0.81% | +19.31% |
| Market Cap | 9,161B 59.34B 51.39B 48.47B 43.99B 82.46B 5,669B 83.18B 575B 223B 2,889B 223B 218B | P/E 2027 * |
45.4x | P/E 2028 * | 28.9x |
|---|---|---|---|---|---|
| Enterprise Value | 13,067B 84.65B 73.31B 69.14B 62.75B 118B 8,087B 119B 820B 317B 4,121B 318B 311B | EV / Sales 2027 * |
2.78x | EV / Sales 2028 * | 2.69x |
| Free-Float |
99.26% | Yield 2027 * |
3.56% | Yield 2028 * | 3.63% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| TAK | Delayed | |
CBOE
| TAK | Real-time | |
|
London S.E.
| 0A87 | Delayed | |
|
Deutsche Boerse AG
| TKDA | Delayed | |
|
Börse Stuttgart
| TKDA | Delayed | |
|
Tradegate
| TKDA | Real-time | |
|
Boerse Muenchen
| TKDA | Real-time |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | +1.86% | ||
| 1 week | +0.81% | ||
| Current month | +3.45% | ||
| 1 month | +6.96% | ||
| 3 months | +16.91% | ||
| 6 months | +4.67% | ||
| Current year | +19.31% |
| 1 week | 18.1 |  | 18.7 |
| 1 month | 17.28 | | 18.84 |
| Current year | 14.84 | | 18.9 |
| 1 year | 12.99 | | 18.9 |
| 3 years | 12.58 | | 18.9 |
| 5 years | 12.28 | | 18.9 |
| 10 years | 12.28 | | 31.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 2024-12-31 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 2024-03-31 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 2022-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 60 | 2015-05-31 |
Steven Gillis
BRD | Director/Board Member | 73 | 2018-12-31 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 2024-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.86% | +0.81% | - | - | 58.91B | |
| +2.02% | -0.96% | +50.69% | +90.07% | 994B | |
| +0.28% | -3.24% | +49.57% | +62.40% | 640B | |
| +1.81% | +2.07% | +19.89% | +73.17% | 454B | |
| +5.00% | +1.23% | +36.64% | +40.84% | 337B | |
| +1.68% | -12.09% | +15.25% | +26.83% | 261B | |
| +3.81% | +1.23% | +3.05% | +14.86% | 246B | |
| +1.10% | -12.75% | +38.03% | +48.31% | 204B | |
| +1.43% | -6.19% | -19.49% | -58.38% | 190B | |
| +1.87% | -3.04% | +27.81% | +89.38% | 178B | |
| Average | +2.07% | -5.76% | +24.60% | +43.05% | 389.42B | |
| Weighted average by Cap. | +1.95% | -4.42% | +33.46% | +57.60% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,701B 30.45B 26.37B 24.87B 22.57B 42.32B 2,909B 42.68B 295B 114B 1,483B 114B 112B | 4,781B 30.97B 26.82B 25.3B 22.96B 43.04B 2,959B 43.42B 300B 116B 1,508B 116B 114B |
| Net income | 196B 1.27B 1.1B 1.04B 944M 1.77B 122B 1.78B 12.32B 4.77B 61.97B 4.78B 4.68B | 322B 2.09B 1.81B 1.71B 1.55B 2.9B 200B 2.93B 20.22B 7.83B 102B 7.85B 7.68B |
| Net Debt | 3,907B 25.31B 21.92B 20.67B 18.76B 35.17B 2,418B 35.47B 245B 94.89B 1,232B 95.07B 92.99B | 3,702B 23.98B 20.77B 19.59B 17.78B 33.33B 2,291B 33.62B 232B 89.93B 1,168B 90.09B 88.13B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-14 | US$18.60 | +1.86% | 2,357,576 |
| 26-09-11 | US$18.26 | +0.83% | 2,150,013 |
| 26-09-10 | US$18.11 | -0.55% | 1,749,287 |
| 26-09-09 | US$18.21 | -0.60% | 1,565,342 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
- TAK Stock
Select your edition
All financial news and data tailored to specific country editions
